Celldex Therapeutics Inc (CLDX) stock news · $2.35B cap
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
This CLDX news page leads with what Celldex Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CLDX yet. We will not pad this page with generic market recap.
Latest reported CLDX revenue for 2026-06-30 was $22.0K. Net income was -$73.5M. Revenue was up 46.7% from 2026-03-31 to 2026-06-30. CLDX currently screens at market cap $2.35B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CLDX stock page; for the tape open the quote page.
CLDX stock news FAQ
What are CLDX's latest revenue and net income?
Latest cached Celldex Therapeutics Inc (CLDX) revenue for Jun 30, 2026 was $22.0K. Net income was -$73.5M. Statements: https://lician.com/financials/cldx
How did CLDX revenue change from the prior cached period?
Cached Celldex Therapeutics Inc (CLDX) revenue was up 46.7% from $15.0K (Mar 31, 2026) to $22.0K (Jun 30, 2026). Statements: https://lician.com/financials/cldx
What is CLDX's market cap?
Celldex Therapeutics Inc (CLDX) market cap is $2.35B on the latest cached fundamentals snapshot.
What kind of company is CLDX?
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Where is CLDX stock news listed?
Cached stock news for Celldex Therapeutics Inc (CLDX) is listed at https://lician.com/news/cldx. Filings: https://lician.com/sec/cldx
Not investment advice.